Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
about
The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cellsRedox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyaninAnaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulonsDual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia.RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cellsPseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells.Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin.The hierarchy quorum sensing network in Pseudomonas aeruginosa.Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increaseDefective adenosine-stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling.Pseudomonas aeruginosa-induced bleb-niche formation in epithelial cells is independent of actinomyosin contraction and enhanced by loss of cystic fibrosis transmembrane-conductance regulator osmoregulatory function.Innate Immune Signaling Activated by MDR Bacteria in the AirwayPyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections.Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles.Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa.The role of toll-like receptors in acute and chronic lung inflammation.The bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways.The challenges and promises of new therapies for cystic fibrosis.Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.Lung cell-specific modulation of LPS-induced TLR4 receptor and adaptor localization.Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa.The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways.Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders.Increased IL-8 production in human bronchial epithelial cells after exposure to azithromycin-pretreated Pseudomonas aeruginosa in vitro.Surfactant protein A blocks recognition of Pseudomonas aeruginosa by CKAP4/P63 on airway epithelial cells.NHERF1 and CFTR restore tight junction organisation and function in cystic fibrosis airway epithelial cells: role of ezrin and the RhoA/ROCK pathway.Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection.Impaired interleukin-8 chemokine secretion by staphylococcus aureus-activated epithelium and T-cell chemotaxis in cystic fibrosis.Cystic fibrosis: an-ion transport issue?Modular microfluidic system as a model of cystic fibrosis airways.First synthesis of pentasaccharide glycoform I of the outer core region of the Pseudomonas aeruginosa lipopolysaccharide.Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?Mechanical robustness of Pseudomonas aeruginosa biofilms.Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogen Pseudomonas aeruginosa.Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.CFTR expression and activity from the human CFTR locus in BAC vectors, with regulatory regions, isolated by a single-step procedure.
P2860
Q24657390-3321AC7E-16A5-462A-B920-048502FE256CQ24657425-716641B0-7397-4846-8DF8-1CBFA1246850Q28493012-3AF631FA-5B18-4B06-A475-64200692B059Q30354742-015AC60A-9885-4031-B6FF-9B43B40EEC5DQ30425067-749B0FFB-1B77-4114-B9AC-40003A401D09Q33508834-7F8D16CD-B676-4829-8853-3ED7A5200DF7Q33756667-C60C5C1A-AED7-42A3-9C34-3729B8AB5187Q34520707-5AECE007-E6B1-416C-903B-A5EADB868509Q34864770-4C7F66A5-53B7-42D8-AD55-1891FA67D41CQ35010045-D006ACA2-6A56-4C51-AB5F-63E15FAA9A4BQ35169502-AF4696D8-AA3A-4859-A8CB-194296D9B6E6Q35172336-DC8134F5-FC39-4B64-BAD4-A99D2D7C32E9Q36422470-A2F6DE57-7DA9-4549-A30A-017006BE2977Q36589251-00F7D028-0FC8-40F8-8C9C-DE199E723693Q37246334-5CA4E456-D09A-4BCD-9315-6398BF2D4C41Q37451128-8607699F-B249-44CF-B785-D5B686DF1D04Q37721418-1756EC54-1E55-40B2-8021-4179C290A3D8Q37812405-F6E72EE4-C61D-41AD-9B64-332BC14211DCQ37905157-5323F11A-0F1F-42A1-9ED2-1C0F62FD1154Q38023386-5753062E-2521-45C0-B1DE-D085082616E4Q38182026-5C803363-58A8-4F8F-92FE-1F4C9DB7CB22Q38241199-C502F68A-5A6C-432A-BD01-47B8A09F197DQ38449873-C5A4AB60-A656-4E4B-BA86-3F73591EF750Q38777684-0F98C0EE-2FE1-400F-941B-2CC51AF3B88BQ38807115-0651B319-4F17-4BD0-83DD-4D720BA452A0Q38960863-2A944A56-A4D9-466A-BA74-5F3DAE832748Q39005987-DC541FF8-D0C7-4345-816C-E6B0861F91F5Q39281402-15E519A2-154F-4840-A85C-9A960FBE6FFEQ39281815-5396BC8E-7345-4660-93EA-DAF461A940B3Q39696154-EE44E357-5E5F-404D-8B20-A96013FBBA0CQ39825776-152065DE-243F-41AA-B38A-56FC41BF9FECQ41861225-2F8C62A0-DB47-49E6-891A-0F50BEE743BEQ41869926-993F2D7E-48C0-42F8-86BE-DE319348AAC0Q42133087-09ABCA03-3C0F-422C-BCEC-5AA70228A8A4Q42732058-3F881EAC-0DB6-44CF-9E7E-C17A1CCA4128Q42795493-07C1EA65-3150-4CA9-BAAA-6BF1C1CCCE4AQ43286993-57D02B9F-CB64-48D6-8C8B-D399C9B82DCAQ43647829-70B6653E-7D61-4F14-822C-270F9EC48F14Q44121558-1766FD45-55F3-4072-86A2-511D44A8BE1FQ45859592-799C6D80-CE42-4AF7-8AE4-EA0C2D98963C
P2860
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
@en
type
label
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
@en
prefLabel
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.
@en
P2093
P2860
P1476
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis
@en
P2093
Ahmet Uluer
Catherine Paradis-Bleau
Mihaela Gadjeva
Victoria L Campodónico
P2860
P304
P356
10.1016/J.MOLMED.2008.01.002
P50
P577
2008-02-11T00:00:00Z